156 related articles for article (PubMed ID: 30612724)
1. Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.
Schoos M; Power D; Baber U; Sartori S; Claessen B; Camaj A; Steg P; Ariti C; Weisz G; Witzenbichler B; Henry T; Cohen D; Antoniucci D; Krucoff M; Hermiller J; Gibson C; Chieffo A; Moliterno D; Colombo A; Pocock S; Dangas G; Mehran R
Am J Cardiol; 2019 Mar; 123(5):709-716. PubMed ID: 30612724
[TBL] [Abstract][Full Text] [Related]
2. Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry.
Chandrasekhar J; Baber U; Sartori S; Aquino M; Tomey M; Kruckoff M; Moliterno D; Henry TD; Weisz G; Gibson CM; Iakovou I; Kini A; Faggioni M; Vogel B; Farhan S; Colombo A; Steg PG; Witzenbichler B; Chieffo A; Cohen D; Stuckey T; Ariti C; Pocock S; Dangas G; Mehran R
Int J Cardiol; 2017 Sep; 243():132-139. PubMed ID: 28554669
[TBL] [Abstract][Full Text] [Related]
3. Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.
Faggioni M; Baber U; Sartori S; Chandrasekhar J; Cohen DJ; Henry TD; Claessen BE; Dangas GD; Gibson CM; Krucoff MW; Vogel B; Moliterno DJ; Sorrentino S; Colombo A; Chieffo A; Kini A; Farhan S; Ariti C; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
Circ Cardiovasc Interv; 2019 Apr; 12(4):e007133. PubMed ID: 30998384
[TBL] [Abstract][Full Text] [Related]
4. Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry.
Faggioni M; Baber U; Sartori S; Giustino G; Cohen DJ; Henry TD; Farhan S; Ariti C; Dangas G; Gibson M; Giacoppo D; Krucoff MW; Aquino M; Chandrasekhar J; Moliterno DJ; Colombo A; Vogel B; Chieffo A; Kini AS; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
JACC Cardiovasc Interv; 2017 Apr; 10(7):645-654. PubMed ID: 28330641
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
Baber U; Li SX; Pinnelas R; Pocock SJ; Krucoff MW; Ariti C; Gibson CM; Steg PG; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Iakovou I; Dangas G; Aquino MB; Sartori S; Chieffo A; Moliterno DJ; Colombo A; Mehran R
Circ Cardiovasc Interv; 2018 Mar; 11(3):e006144. PubMed ID: 29870385
[TBL] [Abstract][Full Text] [Related]
6. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.
Mehran R; Baber U; Steg PG; Ariti C; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Berger PB; Iakovou I; Dangas G; Waksman R; Antoniucci D; Sartori S; Krucoff MW; Hermiller JB; Shawl F; Gibson CM; Chieffo A; Alu M; Moliterno DJ; Colombo A; Pocock S
Lancet; 2013 Nov; 382(9906):1714-22. PubMed ID: 24004642
[TBL] [Abstract][Full Text] [Related]
7. Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents.
Yu J; Baber U; Mastoris I; Dangas G; Sartori S; Steg PG; Cohen DJ; Giustino G; Chandrasekhar J; Ariti C; Witzenbichler B; Henry TD; Kini AS; Krucoff MW; Gibson CM; Chieffo A; Moliterno DJ; Colombo A; Pocock S; Mehran R
JACC Cardiovasc Interv; 2016 Jul; 9(14):1461-9. PubMed ID: 27478113
[TBL] [Abstract][Full Text] [Related]
8. Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.
Sorrentino S; Sartori S; Baber U; Claessen BE; Giustino G; Chandrasekhar J; Chandiramani R; Cohen DJ; Henry TD; Guedeney P; Ariti C; Dangas G; Gibson CM; Krucoff MW; Moliterno DJ; Colombo A; Vogel B; Chieffo A; Kini AS; Witzenbichler B; Weisz G; Steg PG; Pocock S; Urban P; Mehran R
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008226. PubMed ID: 32216472
[TBL] [Abstract][Full Text] [Related]
9. Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry.
Joyce LC; Baber U; Claessen BE; Sartori S; Chandrasekhar J; Cohen DJ; Henry TD; Ariti C; Dangas G; Faggioni M; Aoi S; Gibson CM; Aquino M; Krucoff MW; Vogel B; Moliterno DJ; Sorrentino S; Colombo A; Chieffo A; Kini A; Guedeney P; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
JACC Cardiovasc Interv; 2019 May; 12(10):983-992. PubMed ID: 31122354
[TBL] [Abstract][Full Text] [Related]
10. Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry).
Sorrentino S; Giustino G; Baber U; Sartori S; Cohen DJ; Henry TD; Farhan S; Sharma M; Ariti C; Dangas G; Gibson M; Faggioni M; Krucoff MW; Aquino M; Chandrasekhar J; Moliterno DJ; Colombo A; Vogel B; Chieffo A; Kini AS; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
Am J Cardiol; 2018 Nov; 122(10):1638-1646. PubMed ID: 30270177
[TBL] [Abstract][Full Text] [Related]
11. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R
Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638
[TBL] [Abstract][Full Text] [Related]
12. Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry).
Schoos M; Chandrasekhar J; Baber U; Bhasin A; Sartori S; Aquino M; Vogel B; Farhan S; Sorrentino S; Kini A; Kruckoff M; Moliterno D; Henry TD; Weisz G; Gibson CM; Iakovou I; Colombo A; Steg PG; Witzenbichler B; Chieffo A; Cohen D; Stuckey T; Ariti C; Dangas G; Pocock S; Mehran R
Am J Cardiol; 2017 Sep; 120(6):904-910. PubMed ID: 28778417
[TBL] [Abstract][Full Text] [Related]
13. Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry.
Vogel B; Chandrasekhar J; Baber U; Mastoris I; Sartori S; Aquino M; Krucoff MW; Moliterno DJ; Henry TD; Weisz G; Gibson CM; Iakovou I; Kini AS; Farhan S; Sorrentino S; Faggioni M; Colombo A; Steg PG; Witzenbichler B; Chieffo A; Cohen DJ; Stuckey T; Ariti C; Dangas GD; Pocock S; Mehran R
Thromb Haemost; 2019 Oct; 119(10):1704-1711. PubMed ID: 31365942
[TBL] [Abstract][Full Text] [Related]
14. Nonadherence to ticagrelor versus clopidogrel and clinical outcomes in patients with ACS. Results from the CREA-ARIAM registry.
Almendro-Delia M; Padilla-Rodríguez G; Hernández-Meneses B; Blanco-Ponce E; Arboleda-Sánchez JA; Rodríguez-Yáñez JC; Soto-Blanco JM; Fernández-García I; Castillo-Caballero JM; García-Rubira JC; Hidalgo-Urbano R
Rev Esp Cardiol (Engl Ed); 2024 Feb; 77(2):113-124. PubMed ID: 37573968
[TBL] [Abstract][Full Text] [Related]
15. Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.
Ozawa T; Suda M; Ikegami R; Takano T; Wakasugi T; Yanagawa T; Tanaka K; Ozaki K; Hirono S; Minamino T
Int Heart J; 2018 Jan; 59(1):21-26. PubMed ID: 29279531
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
Wimmer NJ; Dufour AB; Cho K; Gagnon DR; Quach L; Ly S; Do JM; Ostrowski S; Michael Gaziano J; Faxon DP; Kinlay S
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1176-1184. PubMed ID: 27860195
[TBL] [Abstract][Full Text] [Related]
17. Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry).
De Filippo O; Kang J; Bruno F; Han JK; Saglietto A; Yang HM; Patti G; Park KW; Parma R; Kim HS; De Luca L; Gwon HC; Iannaccone M; Chun WJ; Smolka G; Hur SH; Cerrato E; Han SH; di Mario C; Song YB; Escaned J; Choi KH; Helft G; Doh JH; Truffa Giachet A; Hong SJ; Muscoli S; Nam CW; Gallone G; Capodanno D; Trabattoni D; Imori Y; Dusi V; Cortese B; Montefusco A; Conrotto F; Colonnelli I; Sheiban I; de Ferrari GM; Koo BK; D'Ascenzo F
Am J Cardiol; 2021 Oct; 156():16-23. PubMed ID: 34353628
[TBL] [Abstract][Full Text] [Related]
18. Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.
Bardají A; Leal M; Arrarte V; Garcia-Moll X; Pérez de Isla L; Bueno H
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27885830
[TBL] [Abstract][Full Text] [Related]
19. International patterns of dual antiplatelet therapy duration after acute coronary syndromes.
Bueno H; Pocock S; Danchin N; Annemans L; Gregson J; Medina J; Van de Werf F
Heart; 2017 Jan; 103(2):132-138. PubMed ID: 27504002
[TBL] [Abstract][Full Text] [Related]
20. Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51.
Gibson CM; Chakrabarti AK; Mega J; Bode C; Bassand JP; Verheugt FW; Bhatt DL; Goto S; Cohen M; Mohanavelu S; Burton P; Stone G; Braunwald E;
J Am Coll Cardiol; 2013 Jul; 62(4):286-90. PubMed ID: 23602776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
